These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15673949)

  • 41. Comparison of the incidence rates of selected gastrointestinal events reported for patients prescribed celecoxib and meloxicam in general practice in England using prescription-event monitoring (PEM) data.
    Layton D; Hughes K; Harris S; Shakir SA
    Rheumatology (Oxford); 2003 Nov; 42(11):1332-41. PubMed ID: 12810929
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Double-blind study to evaluate efficacy and safety of meloxicam 7.5 mg and 15 mg versus mefenamic acid 1500 mg in the treatment of primary dysmenorrhea.
    de Mello NR; Baracat EC; Tomaz G; Bedone AJ; Camargos A; Barbosa IC; de Souza RN; Rumi DO; Martinez Alcala FO; Velasco JA; Cortes RJ
    Acta Obstet Gynecol Scand; 2004 Jul; 83(7):667-73. PubMed ID: 15225193
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An open study to assess the safety and tolerability of meloxicam 15 mg in subjects with rheumatic disease and mild renal impairment.
    Bevis PJ; Bird HA; Lapham G
    Br J Rheumatol; 1996 Apr; 35 Suppl 1():56-60. PubMed ID: 8630639
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Meloxicam.
    Fleischmann R; Iqbal I; Slobodin G
    Expert Opin Pharmacother; 2002 Oct; 3(10):1501-12. PubMed ID: 12387696
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years.
    Goldstein JL; Aisenberg J; Lanza F; Schwartz H; Sands GH; Berger MF; Pan S
    Clin Ther; 2006 Mar; 28(3):340-51. PubMed ID: 16750449
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A randomized controlled trial comparing topical piroxicam gel with a homeopathic gel in osteoarthritis of the knee.
    van Haselen RA; Fisher PA
    Rheumatology (Oxford); 2000 Jul; 39(7):714-9. PubMed ID: 10908688
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinical efficacy comparison between electroacupuncture and meloxicam in the treatment of knee os- teoarthritis at the early and middle stage: a randomized controlled trial].
    Gang J; Mi Y; Wang H
    Zhongguo Zhen Jiu; 2016 May; 36(5):467-70. PubMed ID: 27509602
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of a specific ginger combination on gastropathy conditions in patients with osteoarthritis of the knee or hip.
    Drozdov VN; Kim VA; Tkachenko EV; Varvanina GG
    J Altern Complement Med; 2012 Jun; 18(6):583-8. PubMed ID: 22784345
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Stomach tolerance of non-steroid anti-rheumatic agents. Studies on gastric irritation caused by carprofen in comparison with acetylsalicyclic acid, indomethacin, piroxicam, and diclofenac].
    Bruhn R; Brendl K; Ganote DP; Lücker PW; Scholz HJ
    Fortschr Med; 1982 Sep; 100(36):1661-8. PubMed ID: 6982843
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Arthroscopic evaluation of potential structure-modifying drug in osteoarthritis of the knee. A multicenter, randomized, double-blind comparison of tenidap sodium vs piroxicam.
    Ayral X; Mackillop N; Genant HK; Kirkpatrick J; Beaulieu A; Pippingskiöld P; Will RK; Alava S; Dougados M
    Osteoarthritis Cartilage; 2003 Mar; 11(3):198-207. PubMed ID: 12623291
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lornoxicam, indomethacin and placebo: comparison of effects on faecal blood loss and upper gastrointestinal endoscopic appearances in healthy men.
    Warrington SJ; Debbas NM; Farthing M; Horton M; Johnston A; Thillainayagam A; Turner P; Ferber H
    Postgrad Med J; 1990 Aug; 66(778):622-6. PubMed ID: 2217030
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diclofenac/misoprostol compared with diclofenac in the treatment of osteoarthritis of the knee or hip: a randomized, placebo controlled trial. Arthrotec Osteoarthritis Study Group.
    Bocanegra TS; Weaver AL; Tindall EA; Sikes DH; Ball JA; Wallemark CB; Geis GS; Fort JG
    J Rheumatol; 1998 Aug; 25(8):1602-11. PubMed ID: 9712107
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of piroxicam-beta-cyclodextrin on the gastrointestinal tract.
    Warrington S
    Eur J Rheumatol Inflamm; 1993; 12(4):29-37. PubMed ID: 7805701
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interrelationships between Helicobacter pylori infection, nonsteroidal antiinflammatory drugs and gastroduodenal disease. A prospective study in healthy volunteers.
    Thillainayagam AV; Tabaqchali S; Warrington SJ; Farthing MJ
    Dig Dis Sci; 1994 May; 39(5):1085-9. PubMed ID: 8174421
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A comparison of the efficacy and tolerability of meloxicam and diclofenac in the treatment of patients with osteoarthritis of the lumbar spine.
    Valat JP; Accardo S; Reginster JY; Wouters M; Hettich M; Lieu PL;
    Inflamm Res; 2001 Mar; 50 Suppl 1():S30-4. PubMed ID: 11339519
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Meloxicam tolerance in hypersensitivity to nonsteroidal anti-inflammatory drugs.
    Domingo MV; Marchuet MJ; Culla MT; Joanpere RS; Guadaño EM
    J Investig Allergol Clin Immunol; 2006; 16(6):364-6. PubMed ID: 17153884
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Local tissue tolerability of meloxicam, a new NSAID: indications for parenteral, dermal and mucosal administration.
    Stei P; Kruss B; Wiegleb J; Trach V
    Br J Rheumatol; 1996 Apr; 35 Suppl 1():44-50. PubMed ID: 8630637
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
    Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG
    Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Protective effect of ranitidine in the stomach and duodenum against piroxicam. An endoscopy controlled double-blind study].
    Müller P; Simon B
    Arzneimittelforschung; 1992 Dec; 42(12):1492-4. PubMed ID: 1288514
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Piroxicam-beta-cyclodextrin: effects on gastrointestinal blood loss and gastric mucosal appearance in healthy men.
    Warrington S; Debbas N; Farthing M; Horton M; Umile A
    Int J Tissue React; 1991; 13(5):243-8. PubMed ID: 1806546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.